At the Patel Center for Functional Regeneration, we constantly improve and advance our cutting-edge treatments based on published research, data from over 100,000 patients across the world, and collecting our own patients’ pain and functional outcome data. This allows us to constantly innovate evidence-based treatments, and lets us provide our patients with procedure candidacy and realistic expectations. Much of orthobiologic research is still very early, so it is absolutely essential that physicians collect data to advance the science.
Reviewing data for 182 of our patients over 4 years that were treated with Bone Marrow Aspirate Concentrated cellular therapy (BMAC) for knee conditions, average improvement in pain was 50% or more from 3-36 months, and on average better than an international database of greater than 38,000 patients. Furthermore, 60-100% of patients had >50% benefit in terms of both pain and function.
Reviewing 126 of our neck pain patients treated with Platelet Rich Plasma (PRP) over 3 years, average improvement in pain was 48% by 6 months and over 50% at month 18 and beyond. 66.7-75% of patients had significant improvement in pain or function between 12-24 months, on average better than an international database of greater than 1,700 patients.
Analyzing 471 of our patients with low back conditions treated with Platelet Rich Plasma (PRP) over 5 years, patients averaged nearly 50% improvement in pain or more from 6 to 60 months, with 64-88% of patients demonstrating >50% improvement in pain and function, on average better than an international database of over 18,000 patients.